DERMATITIS

This study is testing an investigational drug called ATI-045 to see if it can reduce the skin rash and severe itching of moderate-to-severe eczema (atopic dermatitis). About 96 adults who haven't gotten enough relief from standard creams will receive either the drug or a placebo …

This small pilot study is testing whether a hypnosis program is a practical way to help children and teenagers manage atopic dermatitis (eczema). It will involve 32 participants aged 8-17 to see if the program is feasible for a future, larger trial. The goal is to see if hypnosis…

This is the first study in humans to test a new potential medication called SHR-1894 for skin conditions like dermatitis. Researchers will give single injections to 40 healthy volunteers to check for side effects and see how the body processes the drug. The main goal is to determ…

This study aims to observe how patients with moderate-to-severe atopic dermatitis (eczema) respond to the medication abrocitinib in real-world, everyday clinical practice. It will follow 200 patients aged 12 and older who are newly prescribed this medication by their doctor. Rese…

This study aims to understand how common eczema treatments, including antibiotics and bleach baths, change the community of bacteria living on the skin. Researchers will observe 130 healthy volunteers and people with moderate-to-severe eczema over one year, collecting skin sample…